|
|
|
Volumn 4, Issue 7, 1998, Pages 24-29
|
|
Can science meet the challenges of the HCV pandemic: new treatment options for chronic hepatitis C.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
RECOMBINANT INTERFERON;
RIBAVIRIN;
VIRUS RNA;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
DISEASE TRANSMISSION;
DRUG COMBINATION;
GENETICS;
GENOTYPE;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
ISOLATION AND PURIFICATION;
TREATMENT OUTCOME;
VIRUS LOAD;
ANTIVIRAL AGENTS;
CLINICAL TRIALS;
DRUG THERAPY, COMBINATION;
GENOTYPE;
HEPACIVIRUS;
HEPATITIS C;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON TYPE I, RECOMBINANT;
RIBAVIRIN;
RNA, VIRAL;
TREATMENT OUTCOME;
VIRAL LOAD;
|
|
EID: 0032106379
PISSN: 1081454X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
